EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The oncogenic potential of 3 different 7 12 di methyl benz a anthracene transformed c 3h 10t 1 2 cell clones at various passages and the importance of the mode of immuno suppression


, : The oncogenic potential of 3 different 7 12 di methyl benz a anthracene transformed c 3h 10t 1 2 cell clones at various passages and the importance of the mode of immuno suppression. European Journal of Cancer 15(4): 515-526

The oncogenic potential of C3H/10T1/2 [mouse] cells which was transformed in vitro with 7,12-dimethylbenz(a)anthracene is reported. The ability of the cells to grow as malignant tumors in syngeneic immunosuppressed mice was used as parameter for oncogenic potential. Cells of types I, II and III were assayed at several dosage levels, i.e., 104 or 106 cells per inoculum, with or without immunosuppression by antithymocyte serum globulin fraction. The studies were performed in several strains of host animals, i.e., male and female syngeneic C3H mice, C3H mice and nude, athymic female mice. Morphological transformation preceded oncogeneic transformation and type I cells could not be established as tumors. Type II and type III cells developed oncogeneic potential only after several passages in culture. Oncogeneic potential was pronounced in the type III cells, and less strongly expressed in type II cells. Also tested were different methods of immunosuppression of the animal against the expression of the oncogeneic potential of DMBA transformed C3H/10T1/2 cells from type II and III clones. Immunosuppression by antithymocyte serum globulin fraction was an effective method of preparing the syngeneic host so that cells with a low oncogeneic potential would grow as tumors, whereas total body irradiation was not effective. For cells with a high oncogeneic potential both ways of immunosuppression were sufficient. Admixing lethally irradiated cells in the cell inoculum slightly enhanced the tumor development from cells with low oncogeneic potential and such addition was clearly effective for cells with a higher oncogeneic potential, both for the antibody-treated and for the irradiated series. The study stresses the importance of immunosuppression by antithymocyte globulins for detecting in vitro transformed weakly oncogeneic cells.


Accession: 006728066

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Saxholm, H.J., 1979: The oncogenic potential of three different 7,12-dimethylbenz(a)anthracene transformed C3H/10T1/2 cell clones at various passages and the importance of the mode of immunosuppression. European Journal of Cancer 15(4): 515-526

Flesher J.W., 1969: Comparative biologic activities of 7 12 di methyl benz a anthracene carcino 7 hydroxy methyl 12 methyl benz a anthracene carcino 7 12 di hydroxymethyl benz a anthracene carcino 4 methoxy 7 12 di methyl benz a anthracene carcino in the sprague dawley female rat. Cancer Research: 403-408

Roder, J.C.; Tyler, L.; Ball, J.K.; Singhal, S.K., 1978: The immuno competence of tumor thymus derived cells and their role in generalized immuno suppression and immuno stimulation following inoculation of di methyl benz anthracene induced leukemia virus in mice. The spleen cells from CFW/D mice injected with dimethylbenzanthracene-induced leukemia virus exhibited a progressive decline in the in vitro response to heterologous erythrocyte antigens in parallel with tumor growth. Cell transfer experiments rev...

Sheikh, Y.M.; Cazer, F.D.; Hart, R.W.; Witiak, D.T., 1980: Bio transformation of 7 12 di methyl benz a anthracene on the genesis of 7 12 di methyl benz a anthracene trans di hydro diols and 7 12 di methyl benz a anthracene 7 methyl and 12 methyl hydroxylated metabolites. Biotransformation of [the carcinogen] DMBA [7,12-dimethylbenz(a)anthracene] in various induced and uninduced [rat liver] S-10 fractions in the presence and absence of hepatic mixed function oxidase inhibitors (.alpha.-naphthoflavone, metyrapone, S...

Gould A.R., 1976: Di methyl benz anthracene and immuno suppression in the syrian golden hamster. Journal Of Dental Researchec Issue B: B62

Bricker S.L.; E.K.frawy A.H.; Mitchell D.F., 1977: Effect of immuno suppression on di methyl benz anthracene induced salivary gland tumors. Journal of Dental Research 56(SPEC ISSUE B): B107

Baird, W.M.; Chemerys, R.; Chern, C.J.; Diamond, L., 1978: Formation of glucuronic acid conjugates of 7 12 di methyl benz a anthracene phenols in 7 12 di methyl benz a anthracene treated hamster embryo cell cultures. Secondary cultures of hamster embryo cells exposed to 0.5 nmol of the carcinogen [G-3H]7, 12-dimethylbenz(a)anthracene (DMBA) per ml medium metabolized more than 90% of the DMBA within 48 h. Samples of medium were extracted with chloroform, methan...

Summerhayes I.; Chen L.B., 1980: Protein kinase in immuno precipitate of 7 12 di methyl benz a anthracene transformed epithelial cells with serum from tumor bearing rabbits. Nature (London) 284(5755): 462-464

Newman M.S.; Cunico R.F., 1972: The synthesis of 5 hydroxymethyl benz a anthracene 5 acetoxymethyl benz a anthracene and 5 methylmercapto 7 12 di methyl benz a anthracene and of 5 7 12 tri methyl benz a anthracene. Journal of Medicinal Chemistry 15(3): 323-325

Zimmermann F.K., 1969: Genetic effects of polynuclear hydro carbons induction of mitotic gene conversion saccharomyces cerevisiae di methyl benz anthracene pyrene benz pyrene benz anthracene di benz anthracene carcino. Zeitschrift fuer Krebsforschung 72(1): 65-71